Abstract Angiogenesis in breast cancer helps fulfill the metabolic demands of the progressing tumor and plays a critical role in tumor metastasis. Therefore, various imaging modalities have been used to characterize tumor angiogenesis. While micro-CT (lCT) is a powerful tool for analyzing the tumor microvascular architecture at micronscale resolution, magnetic resonance imaging (MRI) with its sub-millimeter resolution is useful for obtaining in vivo vascular data (e.g. tumor blood volume and vessel size index). However, integration of these microscopic and macroscopic angiogenesis data across spatial resolutions remains challenging. Here we demonstrate the feasibility of 'multiscale' angiogenesis imaging in a human breast cancer model, wherein we bridge the resolution gap between ex vivo lCT and in vivo MRI using intermediate resolution ex vivo MR microscopy (lMRI). To achieve this integration, we developed suitable vessel segmentation techniques for the ex vivo imaging data and co-registered the vascular data from all three imaging modalities. We showcase two applications of this multiscale, multi-modality imaging approach: (1) creation of co-registered maps of vascular volume from three independent imaging modalities, and (2) visualization of differences in tumor vasculature between viable and necrotic tumor regions by integrating lCT vascular data with tumor cellularity data obtained using diffusion-weighted MRI. Collectively, these results demonstrate the utility of 'mesoscopic' resolution lMRI for integrating macroscopic in vivo MRI data and microscopic lCT data. Although focused on the breast tumor xenograft vasculature, our imaging platform could be extended to include additional data types for a detailed characterization of the tumor microenvironment and computational systems biology applications.
Introduction
Angiogenesis, the process of new blood vessel formation, plays a central role in breast cancer development, invasion and metastasis [1] . Therefore, new approaches for elucidating the angiogenesis pathway and the effects of antiangiogenic therapies in breast cancer are required to confer survival benefits for patients [2] . Much of our understanding of angiogenesis has been the result of preclinical research [3] that includes a wide array of imaging studies [4] . Microscopic imaging with optical methods has revealed different aspects of tumor angiogenesis [5] . For example, intravital microscopy of window chamber tumor models has provided invaluable insights into vascular function, gene expression, the tumor microenvironment and drug delivery [6] [7] [8] . Compared to histology, advanced optical techniques do not require sectioning of the tumor and permit relatively larger spatial coverage. However, since most optical methods cannot image tissue deeper than *1 mm, they are unsuitable for imaging the complete 3D vasculature of tumor xenografts [5] . Furthermore, since angiogenic gene expression has been shown to differ between orthotopically and ectopically (e.g. in window chambers) grown tumors [9] , one requires a technique capable of imaging the whole tumor.
In contrast, one can characterize angiogenesis in vivo on the macroscopic scale using computed tomography (CT) [10] , or magnetic resonance imaging (MRI) [11, 12] . MRI is a versatile imaging modality for assessing tumor angiogenesis because it permits the repeated measurement of numerous angiogenesis-related parameters such as blood volume, vessel size index and vessel permeability [13] . In vivo CT offers analogous parameters for quantifying in vivo angiogenesis [10, 14] , but involves the use of X-ray radiation.
In spite of advances in imaging angiogenesis, integration of imaging data acquired at microscopic and macroscopic spatial scales is challenging for visualization [15] and computational applications [16] . Therefore, the goal of this study was to develop and validate an imaging platform for characterizing breast cancer angiogenesis at multiple spatial scales. We imaged orthotopic MDA-MB-231 human breast cancer xenografts using three imaging modalities: (1) in vivo susceptibility contrast-enhanced MRI at the macroscopic scale (0.1 9 0.1 9 1 mm 3 resolution), (2) ex vivo magnetic resonance microscopy (lMRI) at the mesoscopic scale (40 lm isotropic resolution) and (3) micro-CT (lCT) at the microscopic scale (8 lm isotropic resolution) (Fig. 1 ). Susceptibility contrast-enhanced MRI was used to measure in vivo tumor blood volume, while diffusion-weighted imaging was used to assess tumor cellularity by measuring the apparent diffusion coefficient (ADC). lCT provided high-resolution 3D images of the whole tumor microvasculature without the need for tissue maceration. Co-registration of these complementary tumor angiogenesis data was facilitated by mesoscopic scale lMRI, which exhibits both excellent soft tissue contrast (for co-registration with in vivo MRI) and visualization of blood vessel architecture (for co-registration with lCT) as demonstrated by us earlier [17] .
We demonstrate the utility of our multiscale imaging platform by: generating co-registered blood volume maps from macroscopic, mesoscopic and microscopic angiogenesis data acquired using different contrast mechanisms; and integrating tumor vascular data with complementary information on tumor viability to show how the distribution of tumor blood vessels varies between viable and necrotic tissue. The availability of a preclinical multiscale imaging platform can provide a wealth of clinically relevant information about tumor angiogenesis. This includes identification of novel drug targets, development of novel antiangiogenic therapies, tests of therapeutic efficacy, development of novel clinical biomarkers, correlation of genotype with phenotype and 'bioimage' based computational models for cancer systems biology. a b c Fig. 1 Multiscale and multi-modality imaging of tumor angiogenesis. a In vivo MRI with its range of intrinsic and extrinsic contrast mechanisms enables the assessment of in vivo angiogenic parameters, but has a spatial resolution limited to the macroscopic scale (*100 lm). c Micro-CT (lCT) allows us to visualize blood vessels directly and quantify angiogenesis down to the microscopic spatial scale (*8 lm) of a capillary. b Therefore, here we suggest that MR microscopy (lMRI) with its intermediate (*40 lm) spatial resolution is useful for integrating angiogenesis data from in vivo MRI and lCT.
Materials and methods

Breast cancer model
Human MDA-MB-231 breast cancer cells were cultured in RPMI-1640 medium (Sigma-Aldrich, St. Louis, MO), supplemented with 10 % fetal bovine serum and penicillin-streptomycin (Sigma-Aldrich). Three million cells were orthotopically inoculated in 50 ll of Hanks balanced salt solution (Sigma-Aldrich) in the left thoracic mammary fat pad of ten female athymic NCr nu/nu mice. All animal studies were performed in accordance with the institutional Animal Care and Use Committee guidelines.
Imaging protocols
Tumor xenografts were imaged with in vivo MRI, ex vivo lMRI and lCT. Five tumors were imaged at post inoculation week three (PIW3) and another five at PIW5.
In vivo MRI protocol
For in vivo MRI, mice were anesthetized with a cocktail of ketamine and acepromazine, and the tail veins were cannulated for administration of the superparamagnetic iron oxide contrast agent Feridex Ò (Bayer Healthcare Pharmaceuticals Inc., Wayne, NJ). The mice were placed into a Bruker 9.4 Tesla horizontal bore MRI scanner with an 18 mm solenoid radio frequency (RF) coil and kept under isoflurane anesthesia while the body temperature was maintained at 37°C using a heating blanket. The xenografts were imaged using the following pulse sequences: (1) Diffusion weighted (DW) images were acquired using a DW spin-echo sequence: echo time (TE) = 26.6 ms, repetition time (TR) = 1,000 ms, number of averages (NA) = 2. One non-DW image and three DW-images were acquired with a b-value of *300 s/ mm 2 and diffusion sensitizing gradient orientations of [1, 0, 0] , [0,1,0] and [0,0,1]. (2) T2*weighted (T2*w) images were acquired using a two-dimensional (2D) multi-echo gradient-echo (MGE) sequence with the following parameters: TE = 4.2/7.2/10.2/13.2/16.2/19.2 ms, TR = 800 ms, flip angle (h) = 90°, NA = 4, in-plane resolution = 100 9 100 lm 2 , slice thickness = 1 mm. Next, Feridex Ò (3.73 mg/ml Fe in saline) was injected into the catheterized tail vein at a dose of *25 mg/kg of Fe. After allowing 5 min for the contrast agent to equilibrate, T2*w scans were acquired to obtain post-contrast images.
Tumor sample preparation for ex vivo imaging
After in vivo MRI, each tumor was perfusion fixed followed by perfusion with the radio-opaque silicon-rubber compound Microfil Ò (FlowTech Inc., Carver, MA), according to a method described by us in [17] . After letting the Microfil Ò cure for *60 min, the tumor and surrounding connective tissue were excised and fixed in zinc formalin. To preserve the anterior-posterior orientation of the tumor following excision, a cotton string soaked in Gd-DTPA (Magnevist Ò , Bayer Healthcare Pharmaceuticals) enriched water was attached with superglue along the anterior-posterior axis of the tumor. Two days later, excess connective tissue was trimmed from the tumor while leaving the cotton string attached.
MR microscopy (lMRI) protocol
Twenty-four hours before lMRI, each tumor was immersed in Phosphate Buffered Saline (PBS) doped with 1 mM Magnevist Ò for soft tissue contrast enhancement via shortening of the tissue T1. Right before the lMRI scans, each tumor was placed in an NMR tube filled with Fomblin Ò (Solvay Solexis, Milano, Italy), which provides background free MRI images because it does not supply any proton signal. Fomblin also prevents sample dehydration. Any trapped air bubbles were removed using a vacuum pump.
The tumors were imaged on a vertical bore Bruker 9.4 Tesla spectrometer using a 10 mm volume RF coil (Bruker BioSpin Corp, Billerica, MA) and a T2*w MGE sequence with the following parameters: TE = 4.9/9.7/14.5/19.3/ 24.0/28.8 ms, TR = 150 ms, h = 30°, NA = 14, resolution = 40 9 40 9 40 lm 3 .
lCT protocol
Following lMRI, samples were imaged by Numira Biosciences (Salt Lake City, UT) on a high-resolution, volumetric lCT scanner (lCT40, ScanCo Medical, Brüttisellen, CH). All images were acquired with the following parameters: 8 lm isotropic resolution at 55 kVp, 300 ms exposure time, 2,000 views and 5 frames per view.
Segmentation of tumor blood vessels
Since we were interested in characterizing the tumor vasculature using multiple imaging modalities, it was necessary to develop vessel segmentation pipelines unique to each contrast mechanism. A brief description ensues. First, a tubeness filter was used to determine how 'tubelike' each 3D structure in the image was. This filter is based on the computation of a 3D Hessian matrix which is described in detail in [18] . It first convolves the 3D image data with a spherical Gaussian kernel with a standard deviation 'r' that sensitizes the filter to tubes or vessels of different radii. We determined optimal values of r = 0.8, 1.0, 1.2, 1.4 by visual inspection and based on recommendations for morphological segmentation described in [18] . The outputs of the tubeness filter were combined via a voxel-wise 'maximum' operation (i.e. output intensity of voxel i image3 i = max(image1 i , image2 i )) and a conservative threshold was applied to the result, which identified the most 'tube-like' structures and resulted in an initial binary vascular tree. Second, for regions that exhibited low contrast between the vasculature and tumor tissue, we enhanced the vessel extraction using a C-means clustering approach. The software MIPAV (Medical Image Processing, Analysis, and Visualization; National institute of Health, Bethesda, MD) was used to automatically classify three to five regions of different image intensities in the raw lMRI data. A lower threshold was applied to the tubeness output, which identified vessels in low contrast regions as well as 'non-vascular' structures in the tumor tissue. The latter were removed by masking out the regions of intermediate image intensity determined by the C-means classes.
The tubeness filter was not sensitive to vessels with diameters greater than approximately four lMRI voxels, which led to holes in these vessels, and using larger r would have resulted in an unwanted dilation of smaller vessels. Therefore, in the third step, these vessels were segmented separately using C-means clustering. The class of voxels exhibiting the lowest signal intensity accounted for vessels greater than *80 lm in radius that were not completely segmented in the previous steps. Next, the outputs of all three vessel extraction steps were combined, and a 3D morphological closing operation was performed in ImageJ with a spherical structuring element of one voxel radius to fill remaining holes. Finally, to eliminate small, disconnected objects in the extracted vasculature, 3D regions smaller than six connected pixels determined using a 26-pixel-connected neighborhood were removed.
Due to the excellent soft tissue contrast of lMRI, it was possible to manually mask non-tumor tissue using the segmentation editor in the Amira Ò visualization platform (VSG Inc., Burlington MA). This tumor mask was multiplied with the resulting binary vasculature to exclude nontumor vasculature from the surrounding tissue.
lCT vessel segmentation
Due to the radio-opacity of Microfil Ò , all tumor blood vessels appeared bright in the lCT images and the vasculature was extracted using a similar procedure as for the lMRI data (Fig. 3a) . First, the 3D lCT data were imported into ImageJ and the tubeness filter applied with r = 1.0 and 1.5. The results were combined via a 'maximum' operation and then subjected to a 3D mean filter to fill holes and create a well-connected vascular structure, which was then thresholded to produce a binarized vasculature. This threshold was chosen by visual comparison with the raw data and a compromise was made between segmenting small or low intensity blood vessels, dilating vessels and including noise. The selected threshold resulted in some noise (which was removed in the final processing step) while resultant vessel diameters were visually consistent with the raw data. To fill holes in large caliber blood vessels, a conservative intensity threshold was applied to the raw lCT data to segment vessels larger than approximately four lCT voxels in diameter, which were then combined with the initial binarized vessels. The final binarized vasculature underwent a 3D closing operation and in the final step, regions smaller than 27 connected voxels were removed.
Co-registration of in vivo MRI and lMRI data
The unprocessed in vivo MRI and lMRI data were coregistered using Amira Ò . The string fiducial attached to the tumor to indicate the anterior-posterior axis for ex vivo imaging helped to orient the lMRI dataset relative to the in vivo MRI data. A thorough comparison of the tumor shapes between both datasets was then used to define the final rigid-body transformation for the alignment of the b Fig. 2 Illustration of vessel extraction steps for lMRI data. a Flow chart of segmentation procedure. Letters b-j indicate output images corresponding to each segmentation step. b Slice of raw T2*w lMRI data (TE = 4.9 ms). Blood vessels appear dark due to presence of waterless Microfil. c Result of the tubeness filter after combining the filter outputs using r = 0.8, 1.0, 1.2, 1.4 with a maximum intensity arithmetic operation. d Result of C-means clustering with five classes. The blue arrow indicates class 1 and the red arrows denote classes 3 and 4, respectively. e Result of applying a conservative threshold to the output of the tubeness filter (green), overlaid on the raw lMRI data. f Class 1 from (d) shown in blue. g Result (red) of applying a lower threshold on the output of the tubeness filter and masking out regions corresponding to classes 3 and 4 in (d). h Overlay of (e), (f) and (g). Co-localization of green and red pixels shown in yellow, red and blue overlap shown in purple pixels and all three colors add up to white pixels. i Yellow structures are the combination of (e), (f) and (g) while red voxels were added by the 3D closing operation. j Final extracted blood vessels after 3D region removal of \6 connected voxels. (Color figure online) lMRI tumor volume to the in vivo MRI volume. For the computational execution of the 3D co-registration, a Lanczos interpolation was applied to register the volumes while preserving voxel size. The same transformation was used to co-register the lMRI vascular data and the tumor mask to the in vivo MRI data. The tumor mask was downsampled to the in vivo MRI spatial resolution.
Co-registration of lMRI and lCT data
The co-registration of the unprocessed 3D lCT data to the transformed lMRI data was performed in two steps using Amira Ò .
(1) Since the string fiducial was visible in both lMRI and lCT datasets, it was used for an initial manual alignment of the two image volumes. The transformation was executed using Lanczos interpolation while preserving the voxel size. (2) To improve the manual alignment, two fiducial sets were created by manually placing landmarks on corresponding vessels in the raw lMRI and lCT datasets. Following slice-wise inspection of the 3D lMRI and lCT data, characteristic vessel bifurcations or conspicuous vessels were identified in both datasets. Between 5 and 10 landmarks were set per tumor and used for the rigid-body landmark registration in which the lCT data was automatically aligned with the lMRI data by minimizing the spatial differences between the manually set landmarks in both datasets. The extracted lCT vasculature was transformed with the same parameters as those obtained from the registration of the raw lCT data with the lMRI data.
Assessment of lMRI and lCT blood vessel segmentation by optical microscopy
The quality of the vessel extraction was assessed by visual comparison with optical microscopy of whole mount tumor sections. Due to positive contrast of the Microfil in lCT images, it was possible to segment the superficial tumor blood vessels. The same vessels were then imaged by bright-field microscopy and visually compared to the lCT data. Superficial vessels were not visible in the lMRI data since both the microfilled vessels and background appear dark, so intratumoral vessels were compared with optical microscopy images as follows. A 1 mm thick tumor section was optically cleared by sequential immersion in a 50 % (v/v) water-glycerin mixture followed by increasing concentrations every 24 h to 75, 85 and 100 %. A bright-field image of the tumor section was then acquired at 29 magnification.
Assessment of lMRI and lCT co-registration using blood volume maps
The co-registration of extracted lMRI and lCT vasculature was visually evaluated by overlaying the extracted tumor vasculature obtained from both modalities. Moreover, we compared the co-registered blood volume maps from the two modalities. Fractional blood volume (FBV) maps for lMRI and lCT data were computed by superimposing a spatial grid of 1 mm isotropic voxels on each co-registered dataset and computing the fractional occupancy of vessels within each grid voxel. Linear regression between the lMRI and lCT FBV was used to assess the quality of co-registration and vessel segmentation.
In vivo MRI blood volume maps
It has been shown that the change in the gradient-echo relaxation rate or DR2* (i.e. 1/T2 post * -1/T2 pre *) is a measure of the total blood volume [19] . Thus, for each voxel of the in vivo MGE images, the signal intensity versus echo-time curve was fit with a mono-exponential function, which yielded pre-and post-contrast R2* maps. An F-test was used to select only those voxels for which the full exponential model fit the data significantly better (p \ 0.05) than the reduced constant model. Next we performed a voxel-wise computation of DR2* to create in vivo DR2* maps. Voxels with negative DR2* were excluded from all analyses. The DR2* maps were converted to FBV maps using an equation derived by Tropres et al. [20] :
where c is the gyromagnetic ratio of the 1 H nucleus, B 0 = 9.4 T the external magnetic field strength and Dv = 0.112 ppm (in cgs units) the difference in magnetic susceptibility of blood before and after contrast agent injection as measured by us earlier [21] .
Comparison of multi-modality blood volume measurements
The measurement of the fractional blood volume of the tumors was compared for the three imaging modalities. The in vivo MRI, lMRI and lCT FBV maps were computed using the same spatial grid to make comparison of FBV maps possible. For the purposes of this study, the high spatial resolution (8 lm isotropic) lCT data were treated as the 'gold standard' to which the in vivo MRI and lMRI data were compared. For each imaging modality the FBV values were pooled for PIW3 and PIW5 groups, and quantile-quantile (Q-Q) plots of in vivo MRI and lMRI versus lCT FBV measurements were used to examine the similarity between their distributions. Nineteen quantiles (i.e. the 5th, 10th, 15th … 95th) were computed for the Q-Q plots.
Vascularization in viable and necrotic tumor regions
For a representative tumor sample, we characterized differences in vasculature between viable and necrotic tumor regions of interest (ROI). Since necrotic ROI are known to exhibit a higher apparent diffusion coefficient (ADC) than viable tumor tissue [22] , we used an in vivo ADC map to define the necrotic ROI. The ADC map was computed from the in vivo DW MRI data using DTIStudio (H. Jiang and S. Mori, Radiology Department, Johns Hopkins University, Baltimore, MD, USA). The MR signal intensity depends on the ADC and the b-value according to:
where S and S 0 are the MR signal intensities with and without diffusion weighting, respectively. The ADC value along each gradient direction ADC x , ADC y and ADC z was obtained by solving Eq. 2 for ADC for the three DW images acquired with orthogonal diffusion-sensitizing gradients. The final ADC map is a map of the mean diffusivity:
This ADC map was smoothed, and for one 1 mm slice we used C-means clustering to create four classes of ADC values. The class of highest ADC values of (0.43-0.93) 9 10 -3 mm 2 /s was used to define the necrotic ROI. Voxels with high ADC values at the tumor edges were excluded.
A nearest-vessel distance map was computed for the 1 mm thick section of the lCT image corresponding to the ADC slice. This was done in Amira Ò by calculating the Euclidean distance between every lCT voxel within the 1 mm section and the nearest tumor blood vessel. The nearest-vessel distances were then averaged over the z-direction (i.e. the 1 mm thickness) to obtain a mean nearest-vessel distance map, which was overlaid with the necrotic ROI.
Results
Multi-modality vascular data were acquired from ten breast cancer xenografts at complementary spatial scales. However, motion artifact precluded computation of in vivo blood volume maps for one tumor, and two other tumors could not be imaged with lMRI because of sample dehydration and incomplete tumor exsanguination, respectively. Consequently, these tumors were excluded from further analyses.
Tumor blood vessel segmentation from lMRI data Figure 2b -j illustrates the outputs of the steps necessary to reliably extract the breast tumor vasculature from the 3D lMRI data. Figure 2b shows the raw lMRI data in which the microfilled blood vessels appear dark. Figure 2c shows the result of the ''tubeness'' filter on the raw lMRI data wherein the most tube-like structures are brightest. The result of the C-means clustering for the raw data is presented in Fig. 2d . Figure 2e demonstrates that a ''tubeness'' filter alone was not sufficient for extracting all blood vessels because large caliber tumor blood vessels and those in regions of low contrast-to-noise ratio were not segmented by this method. Figure 2f illustrates how the C-means clustering successfully filled holes in tumor blood vessels larger than *80 lm in radius from the raw lMRI data. Figure 2g shows how the combination of C-means clustering and ''tubeness'' filtering permitted extraction of blood vessels with low contrast relative to surrounding tumor tissue. In Fig. 2h , the results of these three approaches are overlaid, indicating that each step detects a different subset of vessels. In Fig. 2i one can see how the morphological 3D ''closing'' operation is able to fill small holes remaining in the extracted tumor vasculature. Figure 2j illustrates the final extracted 3D tumor vasculature.
Tumor blood vessel segmentation from lCT data
The results of the lCT vessel extraction are demonstrated in Fig. 3b-f . The raw lCT data is displayed in Fig. 3b in which the microfilled blood vessels appear bright. Figure 3c shows the result of the tubeness filter on the raw lCT data, which was then subjected to a 3D mean filter and thresholded to obtain the vasculature shown in red in Fig. 3d . A few remaining holes in large caliber tumor blood vessels remained as illustrated in green. The final extracted tumor blood vessels after 3D morphological closing and small region removal are displayed in Fig. 3e . To better visualize the result of this 3D vessel segmentation pipeline, a volume rendering of the vasculature for a 0.5 mm tumor slice is shown in Fig. 3f .
Assessment of lMRI and lCT derived tumor vasculature
We visually evaluated the extraction of tumor blood vessels from lCT data by directly comparing the resulting vasculature with an optical microscopy image. Figure 4a , b shows that a large number of blood vessels were visible in both the lCT and bright-field image, while vessels smaller than *8 lm were only visible in the latter. A similar comparison was carried out between the lMRI-derived tumor vasculature and bright-field microscopy. Figure 4d , e shows the concordance between the vasculature extracted from lMRI and a bright-field image of a closely matching 1 mm tumor section.
Assessment of lMRI and lCT co-registration
The co-registered and extracted lMRI and lCT vessels were overlaid as shown in Fig. 4c to permit visual assessment of the co-registration. This overlay illustrates the large degree of overlap between the extracted tumor vasculature from the two datasets and confirms the intermodality co-registration. In addition to the spatial overlap, we observed dilation of the lMRI-derived blood vessels compared to both optical microscopy and lCT-derived vessels (Fig. 4c-e) . Small vessels (\20 lm radius) were only visible in the lCT data and not in the lMRI data (Fig. 4c) .
Additionally, we used linear regression for a voxel-wise comparison of the lMRI and lCT-derived FBV (Fig. 4f) . The R 2 values for the linear regression ranged between 0.60 and 0.87 (p \ 0.001) with a mean R 2 of 0.72 (n = 8 tumors). The lMRI-derived FBV overestimated the lCTderived FBV for all tumors.
Comparison of multi-modality blood volume measurements
We used the multi-modality FBV maps to compare the blood volume distribution between the different image contrast mechanisms. Figure 5a -f illustrates the spatial distribution of FBV in a tumor slice from all three imaging modalities. There was good spatial agreement of the lMRI and lCT FBV maps, but absolute FBV values were higher for the lMRI data. The mean lMRI derived FBV was approximately twofold higher for the PIW3 tumors and threefold higher for the PIW5 tumors, compared to the lCT FBV (Fig. 5j) . Although in vivo MRI-derived FBV maps showed less spatial agreement with those computed from lMRI and lCT, all three modalities were capable of visualizing the elevated FBV of the tumor rim compared to the center. The mean in vivo MRI FBV values overestimated those derived from lCT by a factor of two (Fig. 5j) . Q-Q plots of in vivo MRI and lMRI FBV versus lCT FBV were strongly linear for the PIW3 tumors. This suggests that the shapes of the in vivo MRI and lMRI FBV distributions were similar to that of the lCT FBV distribution (Fig. 5g) . Interestingly, the in vivo MRI resembled the lCT FBV distribution more closely than the lMRI did. The slope of the in vivo MRI and lMRI FBV versus lCT FBV Q-Q plot was [1, indicating that the former overestimated the latter by a scaling factor. An identical trend was observed for the Q-Q plots of the PIW5 tumors (Fig. 5h) . Finally, Fig. 5i illustrates that the FBV assessed with all three modalities decreased with tumor volume.
Vascularization in viable and necrotic tumor areas
An application of our multi-modality imaging approach was the characterization of differences in vascularity between viable and necrotic tumor regions. Figure 6 demonstrates how the necrotic region of a tumor, as identified from in vivo ADC measurements, co-localizes with an area exhibiting large distance from the nearest blood vessels, calculated from the lCT data (Fig. 6c) . In addition, an earlier stage (PIW3) tumor with no identifiable necrotic regions exhibited higher ADC values in areas that were at larger distances from the nearest blood vessels (Fig. 6g) . . c Overlay of the lMRI (green) and lCT (orange) derived blood vessels of a breast tumor xenograft after coregistration. On the right is a zoomed version wherein white arrows indicate vessels that can easily be seen in the lMRI and lCT data.
Small vessels were not always visible in the lMRI image while they were resolved with lCT as indicated by red arrows, which is most apparent in the tumor rim. d Cropped view of a slice through the extracted lMRI-derived tumor blood vessels. Red arrows indicate structures that are also visible in the bright-field image in (e). Quantifying angiogenesis-induced changes in the tumor vasculature from medical images is often challenging due to limited contrast-to-noise ratio, image artifacts and spatial resolution limitations. Additionally, each imaging modality has its own unique biophysical contrast mechanism, strengths and weaknesses when it comes to imaging the tumor vasculature as summarized in Table 1 . In this work, we exploit the advantages of in vivo MRI and ex vivo lMRI and lCT to develop an integrated platform for characterizing angiogenesis at multiple spatial scales in a human breast cancer model. Due to its high spatial resolution, lCT is able to resolve blood vessels down to the capillary level [23] . Although the 8 lm isotropic resolution lCT employed in this study cannot resolve the smallest capillaries (*2-3 lm diameter) and angiogenic sprouts, we were able to confirm with optical microscopy that lCT could recapitulate the 3D tumor vasculature down to *8 lm diameter vessels. Moreover, our lCT data is 3D, covers the whole tumor and tumor vessel radii over several orders of magnitude. Therefore, we regarded lCT as the 'gold standard' for 3D Others have also demonstrated the utility of lCT for quantifying tumor angiogenesis down to the capillary level [23] , as well as for validating tumor vascular response to antiangiogenic therapies [24] [25] [26] . Moreover, we recently demonstrated lCT's usefulness as a tool for validating the accuracy of in vivo susceptibility-contrast based MRI biomarkers of breast cancer angiogenesis such as the FBV, vessel size index and vessel density [21] . In this study, we employed 'mesoscopic' scale lMRI to facilitate co-registration between macroscopic in vivo MRI and microscopic lCT angiogenesis data. The intermediate (*40 lm) spatial resolution of lMRI in conjunction with its excellent soft tissue contrast facilitates co-registration and distinguishing tumor tissue from normal tissue for ROI analyses. The spatial resolution of lMRI is limited by the MRI scanner hardware such as the magnetic field and gradient strengths, and by the acquisition time that increases with spatial resolution. In the current study, the intermediate spatial resolution of lMRI did not permit imaging of vessels smaller than 20 lm in radius while the median vessel radius assessed using lCT was *10 lm [21] . Consequently, partial volume effects led to overestimation of absolute blood vessel size by lMRI, and the lMRI-derived FBV values were approximately twofold to threefold higher than those derived from lCT. However, in spite of this resolution limitation, lMRI-visible vessels greatly enhance the co-registration of in vivo MRI and lCT data to enable multiscale imaging of the tumor vasculature. The strength of lMRI therefore does not lie in resolving small capillaries, but in imaging larger blood vessels while simultaneously providing excellent soft tissue contrast. By exploiting the range of available contrast mechanisms, lMRI can provide detailed information about the tumor tissue that can complement high-resolution vascular images from co-registered lCT data.
In vivo MRI is the only imaging modality used in this study that is translatable to patients for repeated and noninvasive tracking of disease progression and anti-angiogenic treatment response [13, 21] . Subject motion and low spatial resolution make the computation of in vivo angiogenic biomarkers and direct spatial correlation with the lCT data challenging. This was apparent from the coregistered FBV maps of all three modalities wherein the in vivo FBV maps did not exhibit voxel-wise agreement with the ex vivo FBV maps. However, the in vivo FBV maps did show spatial similarities with the ex vivo FBV maps, such as elevated blood volume in the tumor rim compared to the center. In addition, the Q-Q plots validated the usefulness of in vivo FBV as a clinical biomarker for angiogenesis since it resembled the lCT FBV distribution more closely than the lMRI FBV distribution, and Our multi-modality visualization of differences in tumor vascularity between viable and necrotic tumor tissue takes advantage of the high spatial resolution provided by lCT and the sensitivity of diffusion-weighted MRI to the underlying tissue cytoarchitecture. The integration of these complementary physiologic data helps us understand the relationship between tumor vascularization and development of necrosis. In our breast cancer model, necrotic tumor areas co-localized with poorly vascularized areas. Moreover, the distance of voxels in the necrotic areas to the nearest blood vessel often exceeded *200 lm, which is the typical diffusion distance of oxygen in tissue [28] . In addition, smaller tumor regions with higher ADC values tended to exhibit larger distances to the nearest vessel, suggesting that necrotic areas were probably developing because of diffusion-limited hypoxia.
Due to the range of available MRI contrast mechanisms, one can foresee several potential applications of this novel imaging platform. For instance, one could relate in vivo measures of vascular function to the tumor vessel architecture by overlaying maps of K trans (i.e. the volume transfer constant between blood plasma and extracellular, extravascular space) obtained from dynamic contrast enhanced (DCE)-MRI with the well-resolved lCT vasculature. This would facilitate interpretation of K trans maps that depend on both blood flow and vessel permeability [29] . We recently demonstrated that the high resolution lCT-derived vasculature can be used in more realistic computational models of tumor blood flow [30] and in 'bioimage informatics' approaches for simulating tumor hemodynamics [31] . In conjunction with histology, these developments help bridge the genotype to phenotype divide and are a major step towards creating tumor vasculature-based 'digital atlases' for cancer systems biology applications.
More recently, investigators have begun to employ realistic vascular geometries to elucidate the biophysics underlying the different MRI contrast mechanisms [32] as well as improve the accuracy of clinical biomarkers of tumor angiogenesis [33] . For example, Pannetier et al. developed a computational tool for simulating DCE-MRI experiments and validated it by testing it on a 2D mouse brain cortical vascular network acquired using two-photon laser scanning microscopy [34, 35] . We recently extended this approach by incorporating the 'whole-tumor' 3D vasculature in biophysical models of dynamic [36] and steadystate susceptibility contrast (DSC or SSC) MRI [32] .
The multi-modality nature of the present study necessitated the development of suitable vessel segmentation techniques for the 3D lCT and lMRI data, since each imaging method has its own unique contrast mechanism [37] . For optimal results, our technique incorporated vessel enhancement [18] , intensity thresholding and binary morphological operations. Although in some cases, simple intensity thresholding could be applied to isolate vascular structures from the background tumor tissue, we demonstrated that the quality of vessel segmentation (i.e. vessel completeness, elimination of 'holes' and isolated voxels) was greatly improved by additional pre-and post-processing steps. One limitation of our vessel segmentation procedure was that it involved the manual determination of segmentation thresholds. Although this made our procedure operator dependent, it resulted in higher-fidelity tumor vasculature than automatic thresholding alone. Both correlation analysis and visual inspection demonstrated that high-quality co-registration was achievable between the lMRI and lCT-derived tumor vasculature. While it would have been ideal to conduct a vessel-to-vessel co-registration for the whole tumor, even the slightest misalignment between the two vascular structures would affect the computed correlation coefficient. Since sample embedding and fixation for lMRI and lCT imaging can introduce tissue deformation as discussed in [17] , tissue distortions on the order of the lMRI spatial resolution of *40 lm would adversely affect the correlation at the original spatial resolution. Collectively, these data demonstrate that although not without limitations, our multiscale multimodality imaging platform is a valuable tool for studying tumor biology at multiple spatial scales. In addition, although it necessitates the availability of different imaging modalities, the integration of multiscale, multidimensional data is a powerful platform for visualizing and integrating angiogenesis-related data in pre-clinical cancer models.
